论文部分内容阅读
目的观察东菱克栓酶(DF-521)治疗脑梗死的疗效。方法将入选患者随机分为DF-521治疗组及对照组各30例。治疗组除常规治疗外,前3d应用DF-521各5Bu静脉滴注,观察两组患者疗效。结果治疗组疗效明显高于对照组(P<0·05)。结论DF-521治疗急性脑梗死疗效显著,用药过程中未见出血等明显不良反应,安全性高。
Objective To observe the curative effect of DF-521 on cerebral infarction. Methods The patients were randomly divided into DF-521 treatment group and control group of 30 cases. In addition to conventional treatment in the treatment group, before the application of DF-521 each 5Bu intravenous infusion, observation of two groups of patients. Results The treatment group was significantly higher than the control group (P <0.05). Conclusion DF-521 treatment of acute cerebral infarction significant effect, medication during the treatment showed no significant adverse reactions such as bleeding, high safety.